Manickam Rajkumar

Dr. Manickam Rajkumar

Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2025 in Biomedical Materials & Devices
Verified
Journal Article
Closed access
PDF file
DKDharmalingam Kirubakaran
Dharmalingam Kirubakaran
JWJamith Basha Abdul Wahid
Jamith Basha Abdul Wahid
NKNatchimuthu Karmegam
Natchimuthu Karmegam
RJRavisankar Jeevika
Ravisankar Jeevika
LSLatha Sellapillai
Latha Sellapillai
KSK. J. SenthilKumar
K. J. SenthilKumar

31 January 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Manickam RajkumarManickam Rajkumar
Manickam Rajkumar
SPS.I. Davis Presley
S.I. Davis Presley
PGPrabha Govindaraj
Prabha Govindaraj
DKDharmalingam Kirubakaran
Dharmalingam Kirubakaran
FFFarha Farahim
Farha Farahim
SLSellapillai Latha
Sellapillai Latha
Nanotechnology has witnessed remarkable advancements in recent years, capturing considerable attention in diverse biomedical applications. Using the green precipitation method, this study aims to synthesize and characterize chitosan/polyvinyl alcohol-copper oxide nanocomposites (CS/PVA/CuONCs) using Anacardium occidentale plant fruit extract. The CS/PVA/CuONCs were further evaluated in antioxidant, antibacterial and biological activities. In our study results, UV–Vis spectrum analysis of CS/PVA/CuONCs revealed a peak at 430 nm. FTIR analyses confirmed the presence of different functional groups, while the XRD study confirmed the crystalline structure of the synthesized nanocomposites. FESEM-EDAX analysis demonstrated that the CS/PVA/CuONCs exhibited a spherical and rod-like shape, with an average particle size of 48.6 to 96.2 nm. Notably, CS/PVA/CuONCs exhibited higher antioxidant activity, as evidenced by their ABTS activity (83.79 ± 1.57%) and SOD activity (86.17 ± 1.28%). In antibacterial assays, CS/PVA/CuONCs demonstrated inhibition in Escherichia coli at 20.52 ± 0.85 mm and Bacillus subtilis at 19.64 ± 0.87 mm, displaying a zone of inhibition. The CS/PVA/CuONCs exhibited excellent anti-inflammatory potency against COX-1 (67.10 ± 0.58%) and COX-2 (76.39 ± 0.65%). The antidiabetic assay revealed excellent α-amylase inhibition (80.25 ± 1.29%) and α-glucosidase inhibition (84.74 ± 1.42%) activities. Anti-cholinergic activity of AChE was 65.35 ± 0.98% and BuChE was 82.46 ± 1.15% are observed. CS/PVA/CuONCs was shown to have strong cytotoxicity against MCF-7 cell lines. It also had the highest cell viability inhibition, at 13.66 ± 0.58%. The hemolysis activity was found to be 5.38 ± 0.34%. Overall, the study demonstrated that CS/PVA/CuONCs possess remarkably excellent biological activities.

12 September 2023 in OpenNano
Verified
Journal Article
Open access
DKDharmalingam Kirubakaran
Dharmalingam Kirubakaran
KSKuppusamy Selvam
Kuppusamy Selvam
PPPalanisamy Prakash
Palanisamy Prakash
MSMuthugounder Subaramanian Shivakumar
Muthugounder Subaramanian Shivakumar
Manickam RajkumarManickam Rajkumar
Manickam Rajkumar

15 January 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Manickam RajkumarManickam Rajkumar
Manickam Rajkumar
SPS.I. Davis Presley
S.I. Davis Presley
NTNathiya Thiyagarajulu
Nathiya Thiyagarajulu
KGKoyeli Girigoswami
Koyeli Girigoswami
GJGopalarethinam Janani
Gopalarethinam Janani
MKMohammad Rashid Khan
Mohammad Rashid Khan
Nanotechnology has experienced significant advancements, attracting considerable attention in various biomedical applications. This innovative study synthesizes and characterizes Ge/PLA/AuNCs (gelatin/PLA/gold nanocomposites) using Syzygium cumini extract to evaluate their various biomedical applications. The UV–Visible spectroscopy results in an absorption peak at 534 nm were primarily confirmed by Ge/PLA/AuNCs synthesis. The FTIR spectrum showed various functional groups and the XRD patterns confirmed the crystalline shape and structure of nanocomposites. The FESEM and HRTEM results showed a oval shape of Ge/PLA/AuNCs with an average particle size of 21 nm. The Ge/PLA/AuNC’s remarkable antioxidant activity, as evidenced by DPPH (70.84 ± 1.64%), ABTS activity (86.17 ± 1.96%), and reducing power activity (78.42 ± 1.48%) at a concentration of 100 μg/mL was observed. The zone of inhibition against Staphylococcus aureus (19.45 ± 0.89 mm) and Echericia coli (20.83 ± 0.97 mm) revealed the excellent antibacterial activity of Ge/PLA/AuNCs. The anti-diabetic activity of Ge/PLA/AuNCs was supported by inhibition of α-amylase (82.56 ± 1.49%) and α-glucosidase (80.27 ± 1.57%). The anti-Alzheimer activity was confirmed by inhibition of the AChE (76.37 ± 1.18%) and BChE (85.94 ± 1.38%) enzymes. In vivo studies of zebrafish embryos showed that Ge/PLA/AuNCs have excellent biocompatibility and nontoxicity. The SH-SY5Y cell line study demonstrated improved cell viability (95.27 ± 1.62%) and enhanced neuronal cell growth following Ge/PLA/AuNCs treatment. In conclusion, the present study highlights the cost-effective and non-toxic properties of Ge/PLA/AuNCs. Furthermore, it presents an attractive and promising approach for various future biomedical applications.

25 June 2024 in Journal of Molecular Structure
Verified
Journal Article
Closed access
DKDharmalingam Kirubakaran
Dharmalingam Kirubakaran
KSKuppusamy Selvam
Kuppusamy Selvam
MDMeiyapparayan Dhaneeshram
Meiyapparayan Dhaneeshram
MSMuthugounder Subramanian Shivakumar
Muthugounder Subramanian Shivakumar
Manickam RajkumarManickam Rajkumar
Manickam Rajkumar
ASAlagarsamy Shanmugarathinam
Alagarsamy Shanmugarathinam

10 October 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Manickam RajkumarManickam Rajkumar
Manickam Rajkumar
KVKaruppaiya Vimala
Karuppaiya Vimala
DTDarwin Dasan Tamiliniyan
Darwin Dasan Tamiliniyan
RTRamasundaram Thangaraj
Ramasundaram Thangaraj
RJRamakrishnan Jaganathan
Ramakrishnan Jaganathan
SKSoundarapandian Kannan
Soundarapandian Kannan